tall brochure lighter - del biopharmadelbiopharma.com/del_biopharma_brochure.pdfof medicinal...

2
Services Include • Design and Implementation of Medicinal Chemistry Programs • Initiation and Management of CRO Activities • Corporate Due Diligence • IP Consulting • Laboratory Design and Outfitting • Custom Organic Synthesis DEL BioPharma (650) 704-3051 [email protected] www.DELbiopharma.com Founder Daniel E. Levy received his Ph.D. in organic chemistry from MIT and his B.S. degree from the University of California - Berkeley. Since 1992, Dr. Levy has worked with companies in all capacities from consultant to director. His broad experience in drug discovery provides him a unique perspective enabling him to address issues at the interface of chemistry and biology long before they impede progress.

Upload: others

Post on 25-Aug-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Tall Brochure Lighter - DEL BioPharmadelbiopharma.com/DEL_BioPharma_Brochure.pdfof Medicinal Chemistry Programs •Initiation and Management of CRO Activities •Corporate Due Diligence

Services Include• Design and Implementation

of Medicinal ChemistryPrograms

• Initiation and Managementof CRO Activities

• Corporate Due Diligence

• IP Consulting

• Laboratory Design andOutfitting

• Custom Organic Synthesis

DEL BioPharma(650) 704-3051

[email protected]

Founder Daniel E. Levy receivedhis Ph.D. in organic chemistry fromMIT and his B.S. degree from theUniversity of California - Berkeley.Since 1992, Dr. Levy has workedwith companies in all capacitiesfrom consultant to director. Hisbroad experience in drug discoveryprovides him a unique perspectiveenabling him to address issues atthe interface of chemistry andbiology long before they impedeprogress.

Page 2: Tall Brochure Lighter - DEL BioPharmadelbiopharma.com/DEL_BioPharma_Brochure.pdfof Medicinal Chemistry Programs •Initiation and Management of CRO Activities •Corporate Due Diligence

“Daniel's strengths include his attention todetail in designing synthetic routes andapproaching interdisciplinary problems. Hehas been able to quickly move his projectsforward by focusing his team’s energies onreaching critical decision points.” - Barry Hart,Senior Scientist at Scios

“I facilitated Dan's inclusion in a project for aclient of mine to devise and manage asynthetic program offshore. He clearly had agreat base relationship to draw on with thesubcontractor. He followed the program at alevel of detail that no one in the companycould have done and made many creativesuggestions to keep the program on track. Iwould hire Dan again in a heartbeat for thiskind of project or as a manager for a muchlarger in-house synthetic program in acompany.” - Terry Burkoth, Owner at PaceLineConsulting

“Dan has proven to be a major asset to ourcompany by pushing forward our developmentefforts with a close focus on strategy.” - BrianSefton, CEO at Pharmadyn

“Daniel is a very creative and competentsynthetic organic chemist, and he hasdemonstrated through this project to me and tomy team his ability to move into a new areaand adapt quickly to produce real results. Irecommend him highly to anyone seeking aconsulting chemist as a partner.” - StevenChamow, Senior Vice President at IntradigmCorporation

• Design and Implementation ofMedicinal Chemistry Programs

- Efficient project planning- Immediate program execution- Reduced cost of laboratory

services- No need for committed

overhead/infrastructure

• Initiation and Management ofCRO Activities

- Sourcing, RFP generation andvendor selection

- Effective technology transfer andoversight

- Project management andtroubleshooting

- Well connected with both foreignand domestic CROs

• Corporate Due Diligence- Third party evaluation of strategic

and scientific viability

• IP Consulting- Design and expansion of project-

specific intellectual property- Patent drafting services from

claims to complete applications

• Laboratory Design and Outfitting

• Custom Organic Synthesis

Cut research costs and protect operating capital with DEL BioPharmaExpert oversight of drug discovery programs from lead identification through early preclinical

Medicinal chemistry strategiesdesigned to proactively address:

• PK/ADME• Formulation• Toxicity• Scale-up

Extensive experience targeting:

• Kinases• GPCRs• ADP receptors• Matrix metalloproteinases• Cell adhesion molecules

Organic chemistry expertise withmultiple structural classesincluding:

• Sugars/glycomimetics• Peptides/peptidomimetics• Nucleosides• Heterocycles• PEGs• Lipids